Method Article

Integrating Network Pharmacology to Investigate Cinnamaldehyde's Protective Effect Against Oxaliplatin-induced Neurotoxicity

DOI:

10.3791/69013

November 28th, 2025

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This study investigates the protective effects of cinnamaldehyde (CA) against oxaliplatin (OXA)-induced damage in rat dorsal root ganglion (DRG) cells. The underlying mechanism involves suppression of the JAK2/STAT3 signaling pathway and activation of the SLC7A11-GSH-GPX4 pathway, as revealed through network pharmacology and experimental validation.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This study investigates the protective effects of cinnamaldehyde (CA) against oxaliplatin (OXA)-induced damage in rat dorsal root ganglion (DRG) cells. The pharmacological activities of CA were analyzed, and its potential targets, along with those of its metabolites, were identified using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), Integrative Pharmacology-based Network Computational Research Platform of Traditional Chinese Medicine (TCMIP), and PharmMapper platforms. The CCK-8 assay is used to determine the optimal concentrations of drugs, while malondialdehyde (MDA) assays are applied to assess the level of lipid peroxidation. Intracellular levels of Fe2+ and reactive oxygen species (ROS) were quantified using fluorescent probes. The impact of CA on protein expression levels, including p-STAT3, XCT, and GPX4, in OXA-treated DRG cells was examined via immunoblotting. Network pharmacology analysis identified 14 overlapping targets among "CA-neuropathic pain (NP)-ferroptosis". Experimental results demonstrated that a 24 h treatment with 4.0 µmol/L CA yielded optimal effects, significantly reducing MDA, Fe2+, and ROS levels in DRG cells (P < 0.05). Furthermore, CA treatment downregulated the expression of JAK2, STAT3, p-STAT3, TFRC, ErbB-1, and nuclear factor-kappa B (NF-κB) (P < 0.05) while upregulating XCT, GPX4, and FTH1 expression (P < 0.05). These findings suggest that CA mitigates OXA-induced damage in DRG cells by inhibiting the JAK2/STAT3 signaling pathway and activating the SLC7A11-GSH-GPX4 axis.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

In recent years, ferroptosis, as a non-apoptotic cell death mode, has been proven to be involved in the tissue damage induced by various chemotherapeutic drugs. The core mechanism of ferroptosis is the accumulation of iron-dependent lipid peroxidation products1. Research on the mechanisms of cisplatin neurotoxicity reveals that this drug induces neuronal ferroptosis through multiple pathways, with this process being directly linked to the development of neurotoxicity. Specifically, cisplatin inhibits glutathione peroxidase 4 (GPX4) activity. As a critical "brake molecule" in ferroptosis, the inactivation of GPX4 prevents the clearance o....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

NOTE: The cell line was derived from rat cell lines.

1. Network pharmacology analysis

NOTE: The links can be found in the Table of Materials.

  1. Finding possible targets of CA
    1. Retrieve structural information from the PubChem database and explore the potential biological mechanisms of CA. Subsequently, conduct the target prediction analysis using SwissTargetPrediction, leveraging its advanced computational capabilities.
    2. To enhance the accuracy and comprehensiveness of the analysis, cross-reference the predicted targets with Traditional Chinese Medic....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Network Pharmacology and Molecular Docking
Identification of potential targets of CA: In the comprehensive investigation of CA's pharmacological activity, 60 potential targets were meticulously curated from an extensive review of relevant literature. To further expand the scope of the analysis, an additional 12 potential targets associated with CA were identified through the TCMSP database. For enhanced accuracy and thoroughness, the advanced predictive capabilities of the SwissTargetPrediction.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Ferroptosis, a recently identified mode of cell death, is characterized by excessive intracellular iron accumulation and lipid peroxidation. Morphologically, ferroptosis manifests as mitochondrial shrinkage, loss or reduction of cristae structures, and increased membrane density, while the cell membrane and nuclear morphology remain unaffected26. Mechanistically, ferroptosis is driven by glutathione (GSH) depletion and impaired GPX4 activity, preventing the metabolism of lipid peroxides via

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

There are no financial conflicts of interest to disclose

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

We express our heartfelt gratitude for the superior conditions provided by the hospital and its departments, which have enabled us to achieve these results. At the same time, we also extend our sincere thanks to the many members of the laboratory for their tireless efforts and valuable contributions over the years. The hard work of every participant is an indispensable part of our success, and in the future, we will continue to work together to advance progress in the field of medicine. China National Natural Science Foundation (82104838), China Promotion Foundation Spark Program (XH-D001), Liaoning Provincial Key Research and Development Programme (2024JH2/102500062)....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
 GlycineBiofroxx1275KG001
 Tris-baseBiofrooxx1115KG001
0.5  M  Tris-HCl buffer (pH  6.8)Biorad1610799
1 M Tris-Hcl (PH 7.5)BeyotimeST775
1.5  M  Tris-HCl buffer (pH  8.8)Biorad1610798
APSBeyotimeST005
Basic electrophoresis power supplyBIO-RAD PowerPac Basic
BCA Protein Quantification KitBeyotimeP0012
Beta Actin Recombinant antibodyHuabio81115-1-RR
Carbon dioxide incubatorThermo150L
CCK-8 assay kitApexbioK1018
Cell Activity and Cytotoxicity Assay KitBeyotimeC2015M
Cinnamaldehyde(CA)MacklinC805134purity 98%
Decolorizing shakerKylin-BellTS-100
DMEM (Dulbecco's Modified Eagle Medium)BasalMediaL110KJ
DMSOSigmaD2650
dorsal root ganglion (DRG)Fuheng BioFH165Serial number: 20211227-1
DRG complete mediumFuheng BioFH-DRG
ECL luminescent solutionThermo34580
ErbB-1Proteintech06-8471:2000
Fetal  Bovine  SerumMacklinFO193
Ferrous ion detection probe - FerroOrangeDojindoF374
FTH1Cell Signaling Technology4393S1:1000
Gel imaging systemBIO-RAD ChemiDoc Touch
Hanks' Balanced Salt Solution(HBSS)SolarbioH1025
High-speed refrigerated centrifugeEppendorf5804R
Hoechst 33342 Live Cell Staining SolutionBeyotimeC1028
Immunohistochemistry kitBiosharpBS-24-PB
Inverted fluorescence microscope systemLeicaLeica Dmi 8
JAK2 Recombinant Rabbit Monoclonal Antibody [SY0245]HuabioET1607-351:2000
Laboratory inverted phase contrast microscopeLeicaLeica Dmi 1
Low-speed centrifugeEppendorf5804
MDA Content Detection KitSangonD799762
Microplate readerSUNRISE TECAN
Multifunctional microplate readerBMGLABTECH PHERAstar FS
NF-κB p65 Polyclonal antibodyProteintech10745-1-AP1:1000
ParaformaldehydeMacklinP804536
Ponceau staining solutionBeyotimeP0022
Protein MarkerThermo26617
P-STAT3 (Ser727)Cell Signaling Technology9134S1:1000
P-STAT3 (Tyr705)Cell Signaling Technology9145S1:2000
Recombinant Anti-Glutathione Peroxidase 4 Antibody[EPNCIR144]abcamab1250661:1000
Recombinant Anti-XCT antibody[EPR27115-64]abcamab3076011:1000
ROS Assay KitDojindoR252
SDS-PAGE Protein Loading Buffer (6X)BeyotimeP0289
Skimmed milk powderBiosharpBS102-500g
Sodium dodecyl sulfate SDSBiofrooxx3250GR500
STAT3 (F-2)Santa CruzSc-80191:200
TEMEDSolarbio   T8090  
TFRCInvitrogen13-68000.5 µg/mL
Tween80SelleckS6702
Ultra-clean workbenchHDLDL-CJ-2NDI
Upright microscopeOlympusCX 31
Vertical electrophoresisBIO-RAD Mini Protean Tetra
Wet transfer tankBIO-RAD Mini Trans Blot
α-Tubulinα-TubulinER130905
GraphPad PrismStatistical analysis
ImageJ softwareObtain the gray value of the protein blot

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Dolma, S., Lessnick, S. L., Hahn, W. C., Stockwell, B. R. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 3 (3), 285-296 (2003).
  2. Ye, L. F., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Network PharmacologyCinnamaldehyde NeuroprotectionOxaliplatin NeurotoxicityDorsal Root GanglionFerroptosis PathwayJAK2 STAT3 SignalingGPX4 ExpressionLipid Peroxidation AssayReactive Oxygen SpeciesProtein Expression Analysis

Related Articles